Skip to main content

12 October 2026

Last updated: Monday 12 October 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

How induced pluripotent stem cells are becoming a tool for personalised medicine

Thursday 8 September 2011

Interviewee/Contributor

Chris Parker

Organisation

Cellular Dynamics International

Organisations

Maxion Therapeutics Ltd
Evonetix Ltd
Forbion Capital Partners BV
Marks and Clerk Solicitors LLP
Imanova Ltd
On-Kòs Pharma Consulting
AstraZeneca Plc
Forbion
AlzeCure Pharma AB
AstraZeneca Plc and Emulate Inc

Interviewees and Contributers

John Fielden
Jackie Turnbull and David Bates
Kevin FitzGerald
Hugh Davies
Regina Hodits
Karen Wagner
Gregg Sando
Michael E. Hunt
Khalid Ishaque
Mark Vaeck

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Hansa Biopharma adds directors to board

Monday 12 October 2026

Engitix appoints CMO as pipeline advances

Monday 12 October 2026

Hikma Pharmaceuticals names CFO

Monday 12 October 2026

Cyllene Therapeutics names CFO

Monday 12 October 2026

Aerska names genetic drug developer to SAB

Monday 12 October 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form